Enterprise Value (EV)
Paying user area
Try for free
Edwards Lifesciences Corp. pages available for free this week:
- Income Statement
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Analysis of Solvency Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Present Value of Free Cash Flow to Equity (FCFE)
- Current Ratio since 2005
- Price to Earnings (P/E) since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Edwards Lifesciences Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Edwards Lifesciences Corp., current enterprise value calculation
| Current share price (P) | |
| No. shares of common stock outstanding | |
| US$ in thousands | |
| Common equity (market value)1 | |
| Add: Preferred stock, $.01 par value, no shares outstanding (per books) | |
| Total equity | |
| Add: Short-term debt (per books) | |
| Add: Long-term debt (per books) | |
| Total equity and debt | |
| Less: Cash and cash equivalents | |
| Less: Short-term investments | |
| Enterprise value (EV) | |
Based on: 10-K (reporting date: 2021-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Edwards Lifesciences Corp., EV calculation
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Edwards Lifesciences Corp. Annual Report.
3 2021 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
The financial data from 2017 through 2021 displays a consistent upward trend in key equity and valuation metrics.
- Common equity (market value) and total equity
- Both items share identical values over the periods, indicating that total equity is fully represented by common equity market value. The figure grows steadily each year, starting from approximately 28.1 billion in 2017 and rising to around 67.1 billion by the end of 2021. This more than doubles the equity within five years, highlighting significant value growth attributable to potentially increased market capitalization or retained earnings.
- Total equity and debt
- Total equity and debt figures also follow an increasing trajectory, albeit at a somewhat slower rate than equity alone. The value rises from about 29.1 billion in 2017 to nearly 67.7 billion in 2021. This growth suggests incremental increases in leverage or debt alongside equity expansion, though the gap between total equity and total equity plus debt remains relatively narrow throughout the period, implying moderate debt levels relative to equity.
- Enterprise value (EV)
- Enterprise value, representing the total valuation of the company including debt, shows consistent growth in line with equity and total capitalization metrics. It increases from approximately 27.8 billion in 2017 to around 66.3 billion by 2021. The close relationship between EV and total equity and debt figures signifies a stable capital structure with market valuation closely aligned to book equity and debt values.
Overall, the data demonstrates sustained growth in the company’s value and capital base over the five-year period, with equity as the primary driver of expansion. Incremental debt usage appears measured, supporting the company's growth without significantly increasing leverage risk. The alignment between enterprise value and total equity plus debt further indicates market confidence reflecting book values comprehensively.